Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.04 USD 0.01%
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
Other Current Liabilities Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Other Current Liabilities
€298.3m
CAGR 3-Years
150%
CAGR 5-Years
54%
CAGR 10-Years
37%
Genmab A/S
CSE:GMAB
Other Current Liabilities
kr4.3B
CAGR 3-Years
49%
CAGR 5-Years
54%
CAGR 10-Years
18%
Zealand Pharma A/S
CSE:ZEAL
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Other Current Liabilities
kr2B
CAGR 3-Years
193%
CAGR 5-Years
165%
CAGR 10-Years
30%
F
Fluoguide AS
STO:FLUO
Other Current Liabilities
kr2m
CAGR 3-Years
-41%
CAGR 5-Years
104%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Other Current Liabilities
kr80k
CAGR 3-Years
-84%
CAGR 5-Years
-60%
CAGR 10-Years
-37%

See Also

What is Ascendis Pharma A/S's Other Current Liabilities?
Other Current Liabilities
298.3m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Other Current Liabilities amounts to 298.3m EUR.

What is Ascendis Pharma A/S's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
37%

Over the last year, the Other Current Liabilities growth was 584%. The average annual Other Current Liabilities growth rates for Ascendis Pharma A/S have been 150% over the past three years , 54% over the past five years , and 37% over the past ten years .

Back to Top